Carotid Artery Wall Alterations as Intermediate End Points

References

• Zanchetti A. Goals of antihypertensive treatment. Prevention of cardiovascular events and prevention of organ damage. Blood Pressure 1992; 1: 201–211
   PubMedGoogle Scholar
• Guidelines Sub-Committee. 1993 Guidelines for the Management of Mild Hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11: 905–918
   PubMed Web of Science ®Google Scholar
• Zanchetti A., Bond M. G., Hennig M., Neiss A., Dal Mancia G., Paid C., et al. Hypertension and atherosclerosis: information from the European Lacidipine Study on Atherosclerosis. J Cardiovasc Pharmacol., In publication.
   Web of Science ®Google Scholar
• Zanchetti A. Antiatherosclerotic effects of calcium antagonists: methodological problems for their assessment. High Blood Pressure 1994; 3: 339–349
   Google Scholar
• Bond G., Wjlmoth S. K., Enevold G. L, Strickland H. I. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med. 1989; 86: 33–36, (suppl 4A)
   PubMed Web of Science ®Google Scholar
• Mercuri M., Devi K. Quantitative ultrasonographic evaluation of the carotid arteries in hypertension. J Cardiovasc Risk 1995; 2: 27–33
   PubMedGoogle Scholar
• Borhani N., Mercuri M., Borhani P., Buckalew V., Canossa-Terris M., Carr A, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA. 1996; 276: 785–791
   PubMed Web of Science ®Google Scholar
• Zanchetti A. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 1995; 13: S35–S39, (suppl 4)
   Google Scholar
• Agabiti Zanchetti A., Rosei E., Dal Palù C., Leonetti G., Magnani B., Pessina A. for the Verapamil in Hypertension and Atherosclerosis Study (VHAS) Investigators. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens. 1998; 16: 1667–1676
   PubMed Web of Science ®Google Scholar
• Zanchetti A., Bond M. G., Henning M., Neiss A, Mancia G., Dal Palù C., et al. Prevalence and risk factors of carotid intima-media thickness in hypertension. Baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 1998; 16: 949–961
   PubMed Web of Science ®Google Scholar
• O'Leary D. R., Polak J. F., Kronmal R. A., Kittner S. J., Bond M. G., Wolfson S. K., et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992; 23: 1752–1760
   PubMed Web of Science ®Google Scholar
• Veller M. G., Fisher CM, Nicolaides A. N., Renton S., Geroulakos C., Stafford N. J., et al. Measurement of the ultrasonic intima-media complex thickness in normal subjects. J Vase Surg. 1993; 17: 719–725
   PubMed Web of Science ®Google Scholar
• Kauma Päivá H., Unsalo M., Savolainen M. J., Rantala A. O., Kiema T. R., Lilja M., et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens. 1996; 14: 1183–1187
   PubMed Web of Science ®Google Scholar
• Päiváunsalo M., Rantala A. O., Kauma H., Lilja M., Reunanen A, Savolainen M. J., et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound. J Hypertens. 1996; 14: 1433–1439
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Salonen R. Risk factors for carotid and femoral atherosclerosis in hypercholesterolaemic men. J Int Med. 1994; 236: 561–566
   PubMed Web of Science ®Google Scholar
• Lusiani L, Visona A., Castellani V., Ronsisvalle G., Scaldalai E., Carraro L, et al. Prevalence of atherosclerotic involvement of the internal carotid artery in hypertensive patients. Int J Cardiol 1987; 17: 51–56
   PubMed Web of Science ®Google Scholar
• Crouse J. R., Toole J. F., McKinney WM, Dignan M. B., Howard G., Kahl F. R., et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987; 18: 990–996
   PubMed Web of Science ®Google Scholar
• O'Leary D. H., Anderson K. M., Kase C. S., Wolf PA, Kannel W. B. Extracranial carotid atherosclerosis in a general population. The Framingham Heart Study. Stroke 1988; 19(1)43–146
   Google Scholar
• Bonithon-Kopp C., Jouven X., Taquet A, Touboul P.-J., Guize L., Scarabin P.-Y. Early carotid atherosclerosis in healthy middle-aged Frenchwomen. Stroke 1993; 24: 1837–1843
   PubMed Web of Science ®Google Scholar
• Roman M. M. J., Pickering T. G., Pini R., Schwartz J. E., Devereux R. B. Determinants cf cardiac and vascular hypertrophy in hypertension. Hypertension 1995; 26: 369–373
   PubMed Web of Science ®Google Scholar
• Muiesan M. L, Pasini G. F., Salvetti M., Calebich S., Zulli R., Castellano M., et al. Cardiac and vascular structural changes: prevalence and relation to ambulatory blood pressure in a middle aged population in northern Italy: the Vobarno Study. Hypertension 1996; 27: 1046–1053
   PubMed Web of Science ®Google Scholar
• Salonen R., Salonen J. T. Carotid atherosclerosis in relation to systolic and diastolic blood pressure. Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Intern Med. 1991; 23: 23–27
   Web of Science ®Google Scholar
• Heiss G., Sharrett A. R., Barnes R., Chambless L. E., Szklo M., Alzola C. and the ARIC investigators: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991; 134: 250–256
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87: II56–II65, (suppl II)
   PubMed Web of Science ®Google Scholar
• Sutton T. K., Alcorn H. G., Herzog H., Kelsey S. F., Kuller, Morbidity L. H. mortality and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995; 26: 1319–1324
   PubMed Web of Science ®Google Scholar
• Sutton T. K., Wolfson S. K., Kuller L. M. Blood pressure treatment slows the progression of carotid stenosis in patients with isolated systolic hypertension. Stroke 1994; 25: 44–50
   PubMed Web of Science ®Google Scholar
• Mercuri M., Bond M. G., Sirtori C. R., Veglia F., Crepaldi G., Feruglio S, et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Study. Am J Med 1996; 101: 627–634
   PubMed Web of Science ®Google Scholar
• Zanchetti A. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. Clin Exp Hypertens. 1992; A14: 307–331
   Google Scholar
• Rouleau J. L., Parmley W. W., Stevens J., Wikman-Coffelt J., Sievers R., et al. Verapamil suppresses atherosclerosis in cholesterolfed rabbits. JACC 1983; 1: 1453–1460
   Google Scholar
• Sievers R. E., Rashid T., Garrett J., Blumlein S. L, Parmley W. W. Verapamil and diet halt progression of atherosclerosis in cholesterol-fed rabbits. Cardiovasc Drugs Ther 1987; 1: 65–69
   PubMedGoogle Scholar
• Stender S., Ravn H., Hangegaard M., Kjeldsen K. Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbits. Atherosclerosis 1986; 61: 15–23
   PubMed Web of Science ®Google Scholar